These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
379 related items for PubMed ID: 24443950
1. A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI). Blümel JE, Chedraui P, Barón G, Benítez Z, Flores D, Espinoza MT, Gomez G, González E, Hernández L, Lima S, Martino M, Montaño A, Monterrosa A, Mostajo D, Ojeda E, Onatra W, Robles C, Saavedra J, Sánchez H, Tserotas K, Vallejo MS, Vallejo C, Collaborative Group for Research of the Climacteric in Latin America (REDLINC). Climacteric; 2014 Aug; 17(4):433-41. PubMed ID: 24443950 [Abstract] [Full Text] [Related]
3. Low use of effective and safe therapies for moderate to severe menopausal symptoms: a cross-sectional community study of Australian women. Worsley R, Bell RJ, Gartoulla P, Davis SR. Menopause; 2016 Jan; 23(1):11-7. PubMed ID: 26240945 [Abstract] [Full Text] [Related]
4. Shared decision-making on the use of hormone therapy: a nationwide survey in the Republic of Korea. An AR, Shin DW, Chun SH, Lee HK, Ko YJ, Lee H, Son KY, Choi HC, Cho B, Lee JK, Kim JG. Menopause; 2014 Jul; 21(7):726-31. PubMed ID: 24378764 [Abstract] [Full Text] [Related]
5. Health characteristics of women beginning postmenopausal hormone therapy: have they changed since the publication of the Women's Health Initiative? Fournier A, Fritel X, Panjo H, Zins M, Ringa V. Menopause; 2014 Jul; 21(7):687-93. PubMed ID: 24378763 [Abstract] [Full Text] [Related]
6. Menopausal symptoms appear before the menopause and persist 5 years beyond: a detailed analysis of a multinational study. Blümel JE, Chedraui P, Baron G, Belzares E, Bencosme A, Calle A, Danckers L, Espinoza MT, Flores D, Gomez G, Hernandez-Bueno JA, Izaguirre H, Leon-Leon P, Lima S, Mezones-Holguin E, Monterrosa A, Mostajo D, Navarro D, Ojeda E, Onatra W, Royer M, Soto E, Tserotas K, Vallejo MS, Collaborative Group for Research of the Climacteric in Latin America (REDLINC). Climacteric; 2012 Dec; 15(6):542-51. PubMed ID: 22530706 [Abstract] [Full Text] [Related]
7. Type of menopause, patterns of hormone therapy use, and hot flashes. Gallicchio L, Whiteman MK, Tomic D, Miller KP, Langenberg P, Flaws JA. Fertil Steril; 2006 May; 85(5):1432-40. PubMed ID: 16566933 [Abstract] [Full Text] [Related]
8. Impaired quality of life among middle aged women: a multicentre Latin American study. Chedraui P, Blümel JE, Baron G, Belzares E, Bencosme A, Calle A, Danckers L, Espinoza MT, Flores D, Gomez G, Hernandez-Bueno JA, Izaguirre H, Leon-Leon P, Lima S, Mezones-Holguin E, Monterrosa A, Mostajo D, Navarro D, Ojeda E, Onatra W, Royer M, Soto E, Tserotas K. Maturitas; 2008 Dec 20; 61(4):323-9. PubMed ID: 19010618 [Abstract] [Full Text] [Related]
9. Prevalence and opinions of hormone therapy prior to the Women's Health Initiative: a multinational survey on four continents. Heinemann K, Rübig A, Strothmann A, Nahum GG, Heinemann LA. J Womens Health (Larchmt); 2008 Sep 20; 17(7):1151-66. PubMed ID: 18774896 [Abstract] [Full Text] [Related]
10. Treatment for the menopause in Central America: use, knowledge, perceptions and attitudes among urban living middle-aged women. Tserotas K, Hernandez L, Morera F, Pineda R, Chedraui P. Gynecol Endocrinol; 2011 Jul 20; 27(7):504-11. PubMed ID: 20626238 [Abstract] [Full Text] [Related]
11. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003. Parazzini F, Progetto Menopausa Italia Study Group. Menopause; 2008 Jul 20; 15(1):164-70. PubMed ID: 17581495 [Abstract] [Full Text] [Related]
12. Quality of life impairment during the female menopausal transition is related to personal and partner factors. Chedraui P, San Miguel G, Avila C. Gynecol Endocrinol; 2009 Feb 20; 25(2):130-5. PubMed ID: 19253110 [Abstract] [Full Text] [Related]
13. A multinational study of sleep disorders during female mid-life. Blümel JE, Cano A, Mezones-Holguín E, Barón G, Bencosme A, Benítez Z, Bravo LM, Calle A, Flores D, Espinoza MT, Gómez G, Hernández-Bueno JA, Laribezcoa F, Martino M, Lima S, Monterrosa A, Mostajo D, Ojeda E, Onatra W, Sánchez H, Tserotas K, Vallejo MS, Witis S, Zúñiga MC, Chedraui P. Maturitas; 2012 Aug 20; 72(4):359-66. PubMed ID: 22717489 [Abstract] [Full Text] [Related]
14. Practice patterns with hormone therapy after surgical menopause. Chubaty A, Shandro MT, Schuurmans N, Yuksel N. Maturitas; 2011 May 20; 69(1):69-73. PubMed ID: 21396791 [Abstract] [Full Text] [Related]
15. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study. Du Y, Scheidt-Nave C, Schaffrath Rosario A, Ellert U, Dören M, Knopf H. Climacteric; 2009 Aug 20; 12(4):329-40. PubMed ID: 19437194 [Abstract] [Full Text] [Related]
16. Hormone therapy use among postmenopausal French women before the publication of the Women's Health Initiative study: duration of use and factors associated with discontinuation. Ringa V, Varnoux N, Piault S, Bréart G. Fertil Steril; 2005 Jun 20; 83(6):1771-9. PubMed ID: 15950650 [Abstract] [Full Text] [Related]
17. Sexual dysfunction in middle-aged women: a multicenter Latin American study using the Female Sexual Function Index. Blümel JE, Chedraui P, Baron G, Belzares E, Bencosme A, Calle A, Espinoza MT, Flores D, Izaguirre H, Leon-Leon P, Lima S, Mezones-Holguin E, Monterrosa A, Mostajo D, Navarro D, Ojeda E, Onatra W, Royer M, Soto E, Vallejo S, Tserotas K, Collaborative Group for Research of the Climacteric in Latin America (REDLINC). Menopause; 2009 Jun 20; 16(6):1139-48. PubMed ID: 19458559 [Abstract] [Full Text] [Related]
18. Factors related to increased daytime sleepiness during the menopausal transition as evaluated by the Epworth sleepiness scale. Chedraui P, Pérez-López FR, Mendoza M, Leimberg ML, Martínez MA, Vallarino V, Hidalgo L. Maturitas; 2010 Jan 20; 65(1):75-80. PubMed ID: 19945237 [Abstract] [Full Text] [Related]
19. Assessing menopausal symptoms among healthy middle aged women with the Menopause Rating Scale. Chedraui P, Aguirre W, Hidalgo L, Fayad L. Maturitas; 2007 Jul 20; 57(3):271-8. PubMed ID: 17329046 [Abstract] [Full Text] [Related]
20. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Gupta P, Sturdee DW, Palin SL, Majumder K, Fear R, Marshall T, Paterson I. Climacteric; 2006 Feb 20; 9(1):49-58. PubMed ID: 16428125 [Abstract] [Full Text] [Related] Page: [Next] [New Search]